Measles vaccination coverage among five-year-old children: implications for disease elimination in Australia

Aust N Z J Public Health. 2003;27(4):413-8. doi: 10.1111/j.1467-842x.2003.tb00419.x.

Abstract

Objectives: To (i) assess under-reporting of measles-mumps-rubella (MMR) vaccinations to the Australian Childhood Immunisation Register (ACIR); (ii) estimate MMR coverage among five-year-old children and the proportion immune to measles infection; (iii) identify factors related to non-uptake of MMR vaccination.

Methods: We analysed ACIR data for a birth cohort of approximately 64,000 children aged five years. The parents of a sample of 506 children with no ACIR record for the second MMR vaccination (MMR2), due at four years of age, were interviewed by telephone to assess under-reporting to the ACIR and reasons for non-uptake of MMR vaccination.

Results: Parents reported that 22% (n = 111) of the surveyed 506 children had received MMR2 before their fifth birthday, and 42% (n = 214) by approximately 5.5 years of age. After correcting for this level of under-reporting to the ACIR, MMR2 coverage for the entire cohort at five years of age was 52.9% (95% CI 52.3-53.4), and increased to 84.1% (95% CI 83.4-84.8) by approximately 5.5 years of age. This was 4.3% and 8.2%, respectively, higher than ACIR coverage estimates at the two ages. Based on the corrected MMR coverage estimates, 93% of the cohort was immune to measles due to vaccination. The most common parent-reported reason for incomplete vaccination was lack of knowledge about the MMR vaccination schedule.

Conclusions: Measles elimination in Australia will require continued effort in vaccination coverage and timeliness among pre-school children. School-entry requirements are important for MMR2 uptake. Strategies are needed to improve reporting to the ACIR for more accurate measurement of coverage.

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Attitude to Health
  • Australia
  • Child, Preschool
  • Cohort Studies
  • Female
  • Humans
  • Immunization Programs / statistics & numerical data*
  • Immunization Schedule
  • Immunization, Secondary / psychology
  • Immunization, Secondary / statistics & numerical data
  • Interviews as Topic
  • Male
  • Measles / prevention & control*
  • Measles Vaccine / therapeutic use*
  • Measles-Mumps-Rubella Vaccine / therapeutic use
  • Patient Compliance / statistics & numerical data*
  • Registries

Substances

  • Measles Vaccine
  • Measles-Mumps-Rubella Vaccine